OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications
Fig 6
Comparative adverse event-profile of two antiemetic drugs.
The largest relative differences in the RRRs of either ondansetron or metoclopramide are visualized for selected adverse events. The blue arrow indicates adverse events which are stronger associated with ondansetron than metoclopramide, the ruby arrow vice versa. Both groups are separated by the dotted line.